Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application Research of Lactobacillus Reuteri in the Treatment of Inflammatory Bowel

NCT06781827 is registered in ClinicalTrials.gov with Wecare Probiotics Co., Ltd. as lead sponsor.

NCT NCT06781827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06781827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application Research of Lactobacillus Reuteri in the Treatment of Inflammatory Bowel
Lead sponsor
Wecare Probiotics Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 30, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease